Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |